BTIG Research upgraded shares of Upstart (NASDAQ:UPST – Free Report) from a neutral rating to a buy rating in a research report released on Monday morning, Marketbeat reports. BTIG Research currently has $43.00 price objective on the stock. Several other equities research analysts have also recently issued reports on UPST. Truist Financial decreased their target […]

BTIG Research upgraded shares of ArriVent BioPharma (NASDAQ:AVBP – Free Report) to a strong-buy rating in a report released on Wednesday morning,Zacks.com reports. Several other research analysts have also issued reports on AVBP. Cantor Fitzgerald began coverage on ArriVent BioPharma in a research report on Monday, December 22nd. They set an “overweight” rating on the […]